Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Genzyme planning 1,000 job cuts

September 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts

Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …
News

Zactima extends progression free survival in other thyroid cancers

September 13, 2010 Research and Development thyroid cancer, zactima

New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …
News

AZ signs cancer development deal

September 13, 2010 Research and Development AstraZeneca, CRT, Cancer Research UK

AstraZeneca has agreed a deal with charity Cancer Research UK to develop a first-in-class cancer treatment. AZD-3965 targets the monocarboxylate …
News

Transgene acquires rights to cancer vaccine

September 10, 2010 Research and Development JX-594, Jennerex, Transgene, cancer vaccine

French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
News

GSK paves way for biopharmaceuticals growth

September 9, 2010 Research and Development GlaxoSmithKline, Lonza, biologics

GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …
News

Universities attack European research grant

September 9, 2010 Research and Development EFPIA, IMI, Innovative Medicines Initiative, academia

A European initiative aimed at fostering new medical research is neglecting its public partners in favour of its private ones, …
News

EU set to pass stricter laws for experiments on animals

September 9, 2010 Research and Development Animal testing, Animal tests

The number of animals used in scientific experiments will be reduced under new EU legislation agreed by the European Parliament …
News

Tzvi Palash joins Protalix BioTherapeutics

September 9, 2010 Manufacturing and Production, Research and Development Portalix BioTherapeutics, appointment, manufacturing and production, research and development

Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …
Appointment
Andreotti

BMS to acquire ZymoGenetics

September 8, 2010 Research and Development, Sales and Marketing BMS, hepatitis

 Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …
News
Dr Meena Jain

Working Life: Dr Meena Jain

September 8, 2010 Business Services, Research and Development Napp, Working Life, careers, recruitment

How did you find your way into your most current role? I’ve been at Napp for four years now having …
Feature

GSK patient recruitment head joins Exco InTouch

September 8, 2010 Research and Development Exco InTouch, appointment, research and development

Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …
Appointment

Pfizer drops brain cancer vaccine

September 7, 2010 Research and Development Celldex Therapeutics, Pfizer, cancer vaccine

Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …
News

Roche signs Alzheimer’s deal with reMYND

September 7, 2010 Research and Development Alzheimer's, Parkinson's, Roche, reMYND

Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
News

Merck averts day in court over Dutch plant closure

September 7, 2010 Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts

Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …
News

Next generation Malaria drug shows promise

September 6, 2010 Research and Development malaria

A Novartis-led collaboration has discovered a novel anti-malarial candidate that could become the first new treatment for the disease in …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025